[Congressional Record (Bound Edition), Volume 150 (2004), Part 5]
[Senate]
[Page 6951]
[From the U.S. Government Publishing Office, www.gpo.gov]




                         ADDITIONAL STATEMENTS

                                 ______
                                 

      RECOGNITION OF CALIFORNIA PHYSICIAN PHILIP C. HOPEWELL, M.D.

 Mrs. FEINSTEIN. Madam President, I rise today to recognize 
Philip C. Hopewell, M.D., of San Francisco, CA. A pioneer in pulmonary 
medicine, Dr. Hopewell is being awarded the Edward Livingston Trudeau 
Medal in recognition of his lifelong contributions to the prevention, 
diagnosis, and treatment of lung disease. Dr. Hopewell has dedicated 
over 30 years researching national and international tuberculosis 
control.
  Dr. Hopewell's commitment to pulmonary disease serves as an example 
for all working to preserve the health of this Nation and the world. 
From the early 1970s, Dr. Hopewell has been concerned with those living 
with tuberculosis. Dr. Hopewell began his career as a consultant in 
tuberculosis control to the Nigerian government in the war-affected 
areas of eastern Nigeria. Later, his interest in tuberculosis control 
in developing countries was fostered by his work in the Pan-American 
Health Organization in 1980-1981 and with the Stop TB Partnership, 
based at the World Health Organization in Geneva in 2003.
  Not only has Dr. Hopewell helped countless tuberculosis patients 
around the globe, he has been instrumental in addressing the problem 
here at home. Dr. Hopewell has been on the faculty at UCSF, based at 
San Francisco General, since 1973, where he served as chief of the 
Division of Pulmonary and Critical Care Medicine from 1989 to 1998 and 
Associate Dean 1998 to 2004. Today, Dr. Hopewell continues to practice 
clinical pulmonary and critical care medicine at San Francisco General 
Hospital, serving as an attending physician on the pulmonary 
consultation service and in the medical intensive care unit.
  In addition to his clinical work, Dr. Hopewell spends a great deal of 
his time as a researcher. Dr. Hopewell's research has enabled more 
specific targeting of control interventions and has helped contribute 
to a nearly 60 percent reduction in the number of new cases of 
tuberculosis in San Francisco in the past decade. In 1981, Dr Hopewell 
became involved in the San Francisco tuberculosis control program 
through the Department of Public Health. From this association, the 
Frances J. Curry National Tuberculosis Center, directed by Dr. Hopewell 
was formed. The Curry Center is one of three CDC-funded model centers 
in the country and provides important opportunities for training and 
research in many aspects of tuberculosis and tuberculosis control.
  Today, I acknowledge Dr. Hopewell for his lifelong accomplishments in 
tuberculosis research and tuberculosis control. I also acknowledge Dr. 
Hopewell's numerous leadership positions in pulmonary medicine. He 
served on the National Advisory Council of the National Institutes of 
Allergy and Infectious Disease, was president of the California 
Thoracic Society, the North American Region of the International Union 
against Tuberculosis and Lung Disease, and the American Thoracic 
Society.
  I am pleased to take this opportunity to recognize Dr. Hopewell for 
his service to the medical community and to our Nation and to 
congratulate him on being selected to receive the American Lung 
Association's Edward Livingston Trudeau Medal.

                          ____________________